401 related articles for article (PubMed ID: 29614786)
1. Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.
Thomas ML; Marcato P
Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29614786
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.
Singh A; Gupta S; Sachan M
Front Cell Dev Biol; 2019; 7():182. PubMed ID: 31608277
[TBL] [Abstract][Full Text] [Related]
3. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.
Wong CC; Li W; Chan B; Yu J
Semin Cancer Biol; 2019 Apr; 55():90-105. PubMed ID: 29665409
[TBL] [Abstract][Full Text] [Related]
4. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
Gezer U; Holdenrieder S
In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers.
Fukushige S; Horii A
Tohoku J Exp Med; 2013 Mar; 229(3):173-85. PubMed ID: 23419314
[TBL] [Abstract][Full Text] [Related]
6. DNA Methylation Cancer Biomarkers: Translation to the Clinic.
Locke WJ; Guanzon D; Ma C; Liew YJ; Duesing KR; Fung KYC; Ross JP
Front Genet; 2019; 10():1150. PubMed ID: 31803237
[TBL] [Abstract][Full Text] [Related]
7. Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer.
Patnaik S; Anupriya
Front Pharmacol; 2019; 10():588. PubMed ID: 31244652
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer.
Rodriguez-Casanova A; Costa-Fraga N; Bao-Caamano A; López-López R; Muinelo-Romay L; Diaz-Lagares A
Front Cell Dev Biol; 2021; 9():622459. PubMed ID: 33614651
[TBL] [Abstract][Full Text] [Related]
9. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
10. Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?
Khan SA; Reddy D; Gupta S
World J Biol Chem; 2015 Nov; 6(4):333-45. PubMed ID: 26629316
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation patterns in cancer: a clinical view.
Paska AV; Hudler P
Biochem Med (Zagreb); 2015; 25(2):161-76. PubMed ID: 26110029
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modifications in solid tumor metastasis in people of African ancestry.
Oladipo EK; Olufemi SE; Adediran DA; Adejumo IO; Jimah EM; Oloke JK; Udekwu CC; Ogunwobi OO
Front Oncol; 2024; 14():1325614. PubMed ID: 38450190
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of prostate cancer: the theories and the clinical implications.
Liao Y; Xu K
Asian J Androl; 2019; 21(3):279-290. PubMed ID: 30084432
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges.
Vaiopoulos AG; Athanasoula KCh; Papavassiliou AG
Biochim Biophys Acta; 2014 Jul; 1842(7):971-80. PubMed ID: 24561654
[TBL] [Abstract][Full Text] [Related]
15. Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies.
Palanca-Ballester C; Rodriguez-Casanova A; Torres S; Calabuig-Fariñas S; Exposito F; Serrano D; Redin E; Valencia K; Jantus-Lewintre E; Diaz-Lagares A; Montuenga L; Sandoval J; Calvo A
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208598
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
Castilho RM; Squarize CH; Almeida LO
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care.
Nicu AT; Medar C; Chifiriuc MC; Gradisteanu Pircalabioru G; Burlibasa L
Front Cell Dev Biol; 2022; 10():861995. PubMed ID: 35465311
[TBL] [Abstract][Full Text] [Related]
18. The role of epigenetics in colorectal cancer.
Coppedè F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
[TBL] [Abstract][Full Text] [Related]
19. Detection of aberrant methylated SEPT9 and NTRK3 genes in sporadic colorectal cancer patients as a potential diagnostic biomarker.
Behrouz Sharif S; Hashemzadeh S; Mousavi Ardehaie R; Eftekharsadat A; Ghojazadeh M; Mehrtash AH; Estiar MA; Teimoori-Toolabi L; Sakhinia E
Oncol Lett; 2016 Dec; 12(6):5335-5343. PubMed ID: 28105243
[TBL] [Abstract][Full Text] [Related]
20. Targeting epigenetics for cancer therapy.
Park JW; Han JW
Arch Pharm Res; 2019 Feb; 42(2):159-170. PubMed ID: 30806885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
